Jane Street’s Alder Biopharmaceuticals ALDR Stock Holding History

Jane Street’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-37,200	Closed	-$911K	–	4840
2016 Q1	$911K	Buy	+37,200	New	+$861K	0.01%	1934

Jane Street's ALDR Position: Q4 2019 in Review

Jane Street sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 301,621 shares — an estimated $5.69M sold.

Jane Street first reported a position in ALDR in Q2 2015 and held it in 7 quarters. The position peaked at $5.69M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Jane Street reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Jane Street sold 301,621 Alder Biopharmaceuticals shares in Q4 2019, an estimated $5.69M.
Jane Street first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 7 quarters.
Jane Street's Alder Biopharmaceuticals position peaked at $5.69M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Jane Street's 13F filing for Q4 2019, filed 14 Feb 2020.